Glutamine in critical illness: The time has come, the time is now

Critical Care Clinics

Volumn 26, Issue 3, 2010, Pages 515-525

  Weitzel, Lindsay Rae B ^a   Wischmeyer, Paul E ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Glutamine; Heat shock protein; Intensive Care; MODS; Nutrition; Sepsis

Indexed keywords

CD45RO ANTIGEN; CD71 ANTIGEN; ESSENTIAL AMINO ACID; GLUTAMINE; GLUTATHIONE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; NONESSENTIAL AMINO ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ANTIOXIDANT ACTIVITY; APOPTOSIS; CATABOLISM; CAUSE OF DEATH; CELL METABOLISM; CELL PROTECTION; CRITICAL ILLNESS; DISEASE SEVERITY; GENE EXPRESSION REGULATION; HOSPITALIZATION; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INCIDENCE; INFLAMMATION; INTENSIVE CARE UNIT; MORTALITY; MULTIPLE ORGAN FAILURE; MUSCLE TISSUE; NUCLEIC ACID SYNTHESIS; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PRIORITY JOURNAL; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; STRESS; TISSUE METABOLISM; UNITED STATES;

CRITICAL ILLNESS; GLUTAMINE; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; INTENSIVE CARE UNITS; MULTIPLE ORGAN FAILURE; PARENTERAL NUTRITION; RISK FACTORS; SEPSIS;

EID: 77954917023     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2010.04.006     Document Type: Review

References (43)

1. Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348(16):1546-1554.
2. Murphy S.L. Deaths: final data for 1998. Natl Vital Stat Rep 2000, 48(11):1-105.
3. Dombrovskiy V.Y., Martin A.A., Sunderram J., et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007, 35(5):1244-1250.
4. Rangel-Frausto M.S., Pittet D., Costigan M., et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273(2):117-123.
5. Fink M.P. Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration?. Crit Care Clin 2002, 18(1):165-175.
6. Gamrin L., Essen P., Forsberg A.M., et al. A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. Crit Care Med 1996, 24(4):575-583.
7. Newsholme E.A., Crabtree B., Ardawi M.S. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q J Exp Physiol 1985, 70(4):473-489.
8. Wilmore D.W. The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr 2001, 131(Suppl 9):2543S-2549S. [discussion: 2550S-1S].
9. Oudemans-van Straaten H.M., Bosman R.J., Treskes M., et al. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 2001, 27(1):84-90.
10. Wischmeyer P.E. Glutamine: role in critical illness and ongoing clinical trials. Curr Opin Gastroenterol 2008, 24(2):190-197.
11. Coeffier M., Dechelotte P. The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome. Nutr Rev 2005, 63(2):65-69.
12. Preiser J.C., Wernerman J. Glutamine, a life-saving nutrient, but why?. Crit Care Med 2003, 31(10):2555-2556.
13. Curi R., Newsholme P., Procopio J., et al. Glutamine, gene expression, and cell function. Front Biosci 2007, 12:344-357.
14. Wischmeyer P.E. Glutamine and heat shock protein expression. Nutrition 2002, 18(3):225-228.
15. Morrison A.L., Dinges M., Singleton K.D., et al. Glutamine's protection against cellular injury is dependent on heat shock factor-1. Am J Phys Cell Physiol 2006, 290(6):C1625-C1632.
16. Wischmeyer P.E. Glutamine: the first clinically relevant pharmacological regulator of heat shock protein expression?. Curr Opin Clin Nutr Metab Care 2006, 9(3):201-206.
17. Pelham H.R. Speculations on the functions of the major heat shock and glucose-regulated proteins. Cell 1986, 46(7):959-961.
18. Weitzel L.R., Mayles W.J., Sandoval P.A., et al. Effects of pharmaconutrients on cellular dysfunction and the microcirculation in critical illness. Curr Opin Anaesthesiol 2009, 22(2):177-183.
19. Weiss Y.G., Bouwman A., Gehan B., et al. Cecal ligation and double puncture impairs heat shock protein 70 (HSP-70) expression in the lungs of rats. Shock 2000, 13(1):19-23.
20. Singleton K.D., Serkova N., Beckey V.E., et al. Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Crit Care Med 2005, 33(6):1206-1213.
21. Singleton K.D., Wischmeyer P.E. Glutamine induces heat shock protein expression via O-glycosylation and phosphorylation of HSF-1 and Sp1. JPEN J Parenter Enteral Nutr 2008, 32(4):371-376.
22. Hamiel C.R., Pinto S., Hau A., et al. Glutamine enhances heat shock protein 70 expression via increased hexosamine biosynthetic pathway activity. Am J Physiol Cell Physiol 2009, 297(6):C1509-C1519.
23. Zachara N.E., Hart G.W. Cell signaling, the essential role of O-GlcNAc!. Biochim Biophys Acta 2006, 1761(5-6):599-617.
24. Wischmeyer P.E., Musch M.W., Madonna M.B., et al. Glutamine protects intestinal epithelial cells: role of inducible HSP70. Am J Physiol 1997, 272(4 Pt 1):G879-G884.
25. Ziegler T.R., Ogden L.G., Singleton K.D., et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med 2005, 31(8):1079-1086.
26. Lappas G.D., Karl I.E., Hotchkiss R.S. Effect of ethanol and sodium arsenite on HSP-72 formation and on survival in a murine endotoxin model. Shock 1994, 2(1):34-39. [discussion: 40].
27. Villar J., Edelson J.D., Post M., et al. Induction of heat stress proteins is associated with decreased mortality in an animal model of acute lung injury. Am Rev Respir Dis 1993, 147(1):177-181.
28. Chu E.K., Ribeiro S.P., Slutsky A.S. Heat stress increases survival rates in lipopolysaccharide-stimulated rats. Crit Care Med 1997, 25(10):1727-1732.
29. Singleton K.D., Beckey V.E., Wischmeyer P.E. Glutamine prevents activation of nf-kappab and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 2005, 24(6):583-589.
30. Fan J., Li Y., Levy R.M., et al. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol 2007, 178(10):6573-6580.
31. Evans M.E., Jones D.P., Ziegler T.R. Glutamine inhibits cytokine-induced apoptosis in human colonic epithelial cells via the pyrimidine pathway. Am J Physiol Gastrointest Liver Physiol 2005, 289(3):G388-G396.
32. Paquette J.C., Guerin P.J., Gauthier E.R. Rapid induction of the intrinsic apoptotic pathway by L-glutamine starvation. J Cell Physiol 2005, 202(3):912-921.
33. Larson S.D., Li J., Chung D.H., et al. Molecular mechanisms contributing to glutamine-mediated intestinal cell survival. Am J Physiol Gastrointest Liver Physiol 2007, 293(6):G1262-G1271.
34. Roth E. Nonnutritive effects of glutamine. J Nutr 2008, 138(10):2025S-2031S.
35. Dechelotte P., Hasselmann M., Cynober L., et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 2006, 34(3):598-604.
36. Bakalar B., Duska F., Pachl J., et al. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med 2006, 34(2):381-386.
37. Novak F., Heyland D.K., Avenell A., et al. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002, 30(9):2022-2029.
38. Yang D.L., Xu J.F. Effect of dipeptide of glutamine and alanine on severe traumatic brain injury. Clin J Traumatool 2007, 10:145-149.
39. Berg A., Bellander B.M., Wanecek M., et al. Intravenous glutamine supplementation to head trauma patients leaves cerebral glutamate concentration unaffected. Intensive Care Med 2006, 32(11):1741-1746.
40. Berg A., Bellander B.M., Wanecek M., et al. The pattern of amino acid exchange across the brain is unaffected by intravenous glutamine supplementation in head trauma patients. Clin Nutr 2008, 27(6):816-821.
41. Heyland D.K.D.R., Day A., et al. Optimizing the dose of glutamine dipeptides and anitoxidants in critically ill patients: a phase I dose-finding study. JPEN J Parenter Enteral Nutr 2007, 31:109-118.
42. McClave S.A., Martindale R.G., Vanek V.W., et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N. JPEN J Parenter Enteral Nutr 2009, 33(3):277-316.
43. Singer P., Berger M.M., Van den Berghe G., et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 2009, 28(4):387-400.